Recent findings have shown that aerobic exercise improves microvascular function and coronary artery function in patients with kidney disease, but further research is needed on the relationship between exercise and kidney function, said Danielle Kirkman, PhD, assistant professor at Virginia Commonwealth University.
Recent findings have shown that aerobic exercise improves microvascular function and coronary artery function in patients with kidney disease, but further research is needed on the relationship between exercise and kidney function, said Danielle Kirkman, PhD, assistant professor at Virginia Commonwealth University.
Transcript
What are some recent findings about the role of exercise in hypertension and kidney disease?
Some recent findings from our group at University of Delaware where I studied my postdoc, we recently found that aerobic exercise in nondialysis kidney disease patients significantly improved microvascular function and coronary artery function, so these are both implicated in the development of hypertension, so certainly this could be playing a role in lowering blood pressure. Previous studies before ours have shown that specifically in the non—kidney disease population, aerobic exercise reduces blood pressure by about 4 to 5 mm Hg. Certainly there’s a lot more research to be done in this field; I think we need some larger multicenter trials looking at the effects of exercise in lowering blood pressure.
With regards to kidney function, I think this is an area that’s still pretty underinvestigated, and it’s really a hot topic for those involved with exercise and chronic kidney disease. We are still trying to figure out whether exercise reduces the progression of kidney disease, whether it improves kidney function and improves perfusion to the kidney.
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
GLP-1 Receptor Agonists Reduce Adverse Cardiovascular Outcomes, Improve Survival
August 2nd 2025Studies found that glucagon-like peptide-1 (GLP-1) receptor agonists were valuable tools in improving outcomes and survival in those with coronary plaque and after ST-elevation myocardial infarction.
Read More